The Eternal Triangle: Benefit, Risk, and Cost of Therapeutic Agents
- 30 November 1996
- journal article
- editorial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 77 (5) , 337-340
- https://doi.org/10.1016/s1081-1206(10)63330-3
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Brompheniramine, Terfenadine, and Placebo in Allergic RhinitisAnnals of Allergy, Asthma & Immunology, 1996
- An overview of current pharmacotherapy in perennial rhinitisJournal of Allergy and Clinical Immunology, 1995
- The Pharmacology and Use of H1-Receptor-Antagonist DrugsNew England Journal of Medicine, 1994
- Allergic RhinitisNew England Journal of Medicine, 1991
- Nasal Pharmacodynamics of Brompheniramine in Perennial RhinitisJAMA Otolaryngology–Head & Neck Surgery, 1988
- The pharmacokinetics and antihistaminic effects of brompheniramineJournal of Allergy and Clinical Immunology, 1982
- Single and repeated dose comparison of three antihistamines and phenylpropanolamine: psychomotor performance and subjective appraisals of sleep.Published by Wiley ,1981
- Effect of the antihistamines, brompheniramine maleate and triprolidine hydrochloride, on performance in man.British Journal of Clinical Pharmacology, 1979
- Oral Facial Dyskinesia Associated with Prolonged Use of Antihistaminic DecongestantsNew England Journal of Medicine, 1975
- Clinical experience with parabromdylamine maleate (Dimetane), a new antihistaminicJournal of Allergy, 1958